VBIO ▲ +8.4% - Valion Bio, Inc.
$VBIO - Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
Valion Bio rose 8.4% following the appointment of life sciences veteran Dean Zikria as interim CEO and related board leadership changes. The executive transition appeared to signal investor confidence in the company's strategic direction under new leadership.
23-SEP-2026 08:00 AM ET
Share this post
More filings for $VBIO
VBIO ▼ -0.5% - Valion Bio, Inc.Oct 9, 2026VBIO ▼ -0.5% - Valion Bio, Inc.Oct 9, 2026VBIO ▼ -6.3% - Valion Bio, Inc.Oct 5, 2026VBIO ▲ +20.1% - Valion Bio, Inc.Sep 30, 2026VBIO ▼ -1.7% - Valion Bio, Inc.Sep 22, 2026VBIO ▼ -5.6% - Valion Bio, Inc.Sep 1, 2026
View full $VBIO filing history →💬 Comments
Loading comments…
Leave a comment
